The findings position SII as a potentially valuable biomarker for risk stratification in patients with COPD and AF, with the identified threshold potentially serving as a clinical decision point for ...
Growth is driven by rising COPD cases due to smoking and pollution, and enhanced therapeutic options like bronchodilators and biologics. Significant investments are improving diagnosis and treatment.
COPD is no longer solely a smoker's illness. Urban pollution, indoor cooking smoke, and even genetics contribute to rising ...
Men and women with chronic obstructive pulmonary disease (COPD), bronchiectasis, and nontuberculous mycobacterial (NTM) lung ...
COPD is one of the most common lung conditions in the country. If you experience shortness of breath, wheezing or difficulty ...
Measuring lung function earlier in life would help identify people at risk of developing chronic obstructive pulmonary disease (COPD) and allow for more timely interventions, according to a new study ...
The CT-based whole-lung radiomic nomogram accurately identifies AECOPD and offers a robust tool for clinical diagnosis and treatment planning.
Chronic obstructive pulmonary disease (COPD) affects approximately 29 million people in the U.S. and is the fourth leading ...
MyHighPlains on MSN
Dr. Brian Weis tells us about COPD Awareness Month
Chronic Obstructive Pulmonary Disease is a progressive lung disease most commonly caused by smoking. Like with many other ...
On Tuesday, the COPD Action Alliance and Representative Karen Gonzalez Pittman talked about the disease's impact across the ...
Seborrheic dermatitis is linked to other epithelial barrier diseases, supporting the epithelial barrier theory as a shared ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback